HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank Andrasik Selected Research

Prescription Drug Overuse

5/2017Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal.
5/2009Treatment of chronic migraine with medication overuse: is drug withdrawal crucial?
5/2009Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal.
5/2008Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy.
4/2008Headache with medication overuse: treatment strategies and proposals of relapse prevention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank Andrasik Research Topics

Disease

17Headache (Headaches)
11/2019 - 06/2002
16Migraine Disorders (Migraine)
05/2019 - 06/2002
7Pain (Aches)
01/2020 - 01/2006
5Prescription Drug Overuse
05/2017 - 04/2008
3Secondary Headache Disorders
01/2019 - 02/2006
3Tension-Type Headache (Tension Headache)
07/2010 - 06/2002
2Primary Headache Disorders
06/2018 - 05/2005
2Headache Disorders (Headache Syndromes)
06/2010 - 09/2008
2Disease Progression
10/2007 - 07/2004
1Asthma (Bronchial Asthma)
01/2021
1Substance-Related Disorders (Drug Abuse)
01/2019
1Opioid-Related Disorders (Opiate Addiction)
01/2019
1Chronic Disease (Chronic Diseases)
06/2018
1Inflammation (Inflammations)
05/2017
1Shoulder Pain
07/2016
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2012
1Migraine without Aura (Common Migraine)
06/2010
1Epilepsy (Aura)
06/2010
1Migraine with Aura (Familial Hemiplegic Migraine)
06/2002

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
06/2018 - 06/2002
2Opioid Analgesics (Opioids)IBA
01/2020 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2018 - 05/2017
2Biological ProductsIBA
05/2017 - 06/2009
2Analgesics (Analgesic Drugs)IBA
10/2007 - 06/2002
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1Narcotics (Narcotic Analgesics)IBA
01/2020
1Type A Botulinum Toxins (Botox)FDA Link
05/2019
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1CatecholaminesIBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
01/2019
1AminesIBA
01/2019
1Naloxone Drug Combination BuprenorphineFDA Link
01/2019
1Complex MixturesIBA
05/2017
1Methylphenidate (Ritalin)FDA LinkGeneric
01/2012
1ginkgolide BIBA
06/2010
1Tryptamines (Triptans)IBA
06/2002

Therapy/Procedure

13Psychology Biofeedback (Biofeedback)
05/2017 - 06/2002
11Therapeutics
06/2018 - 06/2002
3Aftercare (After-Treatment)
07/2016 - 10/2007
2Drug Therapy (Chemotherapy)
11/2019 - 06/2002
2Secondary Prevention
04/2008 - 02/2006
1Meditation
05/2017
1Relaxation Therapy (Relaxation Technique)
07/2010
1Activities of Daily Living (ADL)
06/2010